Endogenous clues promoting remyelination in multiple sclerosis.

Area of Science:

• Neuroscience
• Immunology
• Regenerative Medicine

Background:

• Multiple sclerosis (MS) management has improved with immunomodulators and immunosuppressants, reducing relapses and enhancing quality of life.
• However, preventing long-term disability progression in MS remains a significant challenge, necessitating strategies for myelin repair and axonal protection.
• The brain's inherent capacity for remyelination presents a promising avenue for therapeutic development.

Purpose of the Study:

• To review recent mechanisms underlying myelin repair in the central nervous system.
• To explore the roles of electrical activity and innate immune cells in remyelination.
• To provide an update on therapeutic strategies aimed at promoting endogenous myelin regeneration in multiple sclerosis.

Main Methods:

• Review of recent scientific literature on myelin repair mechanisms in multiple sclerosis.
• Focus on the influence of neuronal electrical activity on remyelination processes.
• Analysis of the involvement of innate immune cells in endogenous myelin repair.

Main Results:

• Recent findings highlight the importance of electrical activity in promoting remyelination.
• Innate immune cells play a crucial role in the self-repair of demyelinated lesions.
• Therapeutic targets for remyelination are being actively investigated, with early-phase trials showing potential.

Conclusions:

• Despite advances, preventing long-term disability in multiple sclerosis requires novel therapeutic approaches.
• Fostering endogenous myelin repair mechanisms, particularly those involving electrical activity and innate immunity, is a key research focus.
• While still in early development, strategies targeting myelin regeneration offer hope for improved outcomes in multiple sclerosis management.